News

NellOne Therapeutics files COVID-19 treatment patent

NellOne Therapeutics files COVID-19 treatment patent

NellOne Therapeutics Inc., the early stage biopharmaceutical company using a talented protein to plot a new future for regenerative medicine, announced today the filing of a provisional patent application around the usage of the NELL1 signaling protein in the...

read more